The results demonstrated that HuR is activated through the PI3K/AKT/mTOR pathway in both GSCs and non-GSCs glioma cells, which suggested that elevation of HuR levels in GSCs compared to non-GSCs glioma cells might be not due to transcriptional regulation. The gene discussed is AKT1; the disease is central nervous system cancer.